Cargando…

The Cost-effectiveness of a Point-of-Care Paper Transaminase Test for Monitoring Treatment of HIV/TB Co-Infected Persons

BACKGROUND: Persons with HIV and tuberculosis (TB) co-infection require transaminase monitoring while on hepatotoxic medications. A novel paper-based, point-of-care transaminase test is in development at an anticipated cost of $1 per test. METHODS: To project long-term clinical outcomes and estimate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajasingham, Radha, Pollock, Nira R, Linas, Benjamin P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197379/ https://www.ncbi.nlm.nih.gov/pubmed/30364559 http://dx.doi.org/10.1093/ofid/ofx194

Ejemplares similares

Field Evaluation of a Prototype Paper-Based Point-of-Care Fingerstick Transaminase Test
por: Pollock, Nira R., et al.
Publicado: (2013)

Performance of an Optimized Paper-Based Test for Rapid Visual Measurement of Alanine Aminotransferase (ALT) in Fingerstick and Venipuncture Samples
por: Jain, Sidhartha, et al.
Publicado: (2015)

Improving Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) Treatment Monitoring in South Africa: Evaluation of an Advanced TB/HIV Course for Healthcare Workers
por: Galagan, Sean, et al.
Publicado: (2016)

Cost-effectiveness of WHO-Recommended Algorithms for TB Case Finding at Ethiopian HIV Clinics
por: Adelman, Max W, et al.
Publicado: (2017)

The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017
por: Ellis, Jayne, et al.
Publicado: (2019)

Challenges Across the HIV Care Continuum for Patients With HIV/TB Co-infection in Atlanta, GA
por: Schechter, Marcos C, et al.
Publicado: (2018)

Effect of Gender on Clinical Presentation of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection
por: Humayun, Maheen, et al.
Publicado: (2022)

A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19—A Call for Clinical Trials
por: Pastick, Katelyn A, et al.
Publicado: (2020)

Relationship Between Hepatitis C Clinical Testing Site and Linkage to Care
por: Assoumou, Sabrina A., et al.
Publicado: (2014)

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
por: Linas, Benjamin P., et al.
Publicado: (2016)

Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda
por: Ramachandran, Anu, et al.
Publicado: (2017)

Antibiotic Prescribing for Acute Respiratory Illnesses in Persons With HIV Compared With Persons Without HIV
por: Keintz, Mackenzie R, et al.
Publicado: (2022)

Cost-effectiveness of Routine Provider-Initiated Testing and Counseling for Children With Undiagnosed HIV in South Africa
por: Stanic, Tijana, et al.
Publicado: (2021)

Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model
por: Chesdachai, Supavit, et al.
Publicado: (2019)

Multisite Laboratory Evaluation of a Dual Human Immunodeficiency Virus (HIV)/Syphilis Point-of-Care Rapid Test for Simultaneous Detection of HIV and Syphilis Infection
por: Bristow, Claire C., et al.
Publicado: (2014)

Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials
por: Lofgren, Sarah M, et al.
Publicado: (2021)

Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts
por: Pollock, Nira R, et al.
Publicado: (2021)

Analysis of Dynamic Efficacy Endpoints of the Nix-TB Trial
por: Solans, Belén P, et al.
Publicado: (2023)

Common Variation in NLRP3 Is Associated With Early Death and Elevated Inflammasome Biomarkers Among Advanced HIV/TB Co-infected Patients in Botswana
por: Ravimohan, Shruthi, et al.
Publicado: (2018)

Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

Prevalence of elevated liver transaminases and their relationship with alcohol use in people living with HIV on anti-retroviral therapy in Uganda
por: Freiman, J. Morgan, et al.
Publicado: (2021)

A Randomized Trial of Point-of-Care Early Infant Human Immunodeficiency Virus (HIV) Diagnosis in Zambia( )
por: Chibwesha, Carla J, et al.
Publicado: (2021)

Predictive Value of Isolated Symptoms for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children Tested During Peak Circulation of the Delta Variant( )
por: Westbrook, Adrianna L, et al.
Publicado: (2022)

Risk Factors for Hospitalization or Death Among Adults With Advanced HIV at Enrollment for Care in South Africa: A Secondary Analysis of the TB Fast Track Trial
por: Calderwood, Claire J, et al.
Publicado: (2022)

Ordering Patterns and Costs of Specialized Laboratory Testing by Hospitalists and House Staff in Hospitalized Patients With HIV at a County Hospital: An Opportunity for Diagnostic Stewardship
por: Bolles, Kathryn, et al.
Publicado: (2019)

Standardized Urine-Based Tuberculosis (TB) Screening With TB-Lipoarabinomannan and Xpert MTB/RIF Ultra in Ugandan Adults With Advanced Human Immunodeficiency Virus Disease and Suspected Meningitis
por: Cresswell, Fiona V, et al.
Publicado: (2020)

The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets
por: Morgan, Jake R, et al.
Publicado: (2017)

Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIV
por: Ellis, Jayne, et al.
Publicado: (2023)

Point-of-Care Tenofovir Urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for Human Immunodeficiency Virus Type 1 (HIV-1) Infection
por: Hermans, Lucas E, et al.
Publicado: (2022)

Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort( )
por: Hewison, Catherine, et al.
Publicado: (2022)

Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus
por: Fisher, Dennis G., et al.
Publicado: (2015)

Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage
por: Bottero, Julie, et al.
Publicado: (2015)

Symptoms of COVID-19 Outpatients in the United States
por: Pullen, Matthew F, et al.
Publicado: (2020)

HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing
por: Curanovic, Dusica, et al.
Publicado: (2023)

Incidental Findings on Coronary Computed Tomography Angiography in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Persons
por: Reinschmidt, Sara, et al.
Publicado: (2018)

Risk of HIV Viral Rebound in the Era of Universal Treatment in a Multicenter Sample of Persons With HIV in Primary Care
por: Liu, Tao, et al.
Publicado: (2023)

Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees
por: Oganezova, Karina, et al.
Publicado: (2020)

Evolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006–2016
por: Flynn, Andrew G., et al.
Publicado: (2017)

Surprisingly Low Levels of Measles Immunity in Persons With HIV: A Seroprevalence Survey in a United States HIV Clinic
por: Rearigh, Lindsey, et al.
Publicado: (2020)

Cardiovascular Disease Risk Management in Persons With HIV: Does Clinician Specialty Matter?
por: Okeke, Nwora Lance, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3h1813sd35nsv85t9vt5p5vc15